New clinical screening strategy to distinguish HNF1A variant-induced diabetes from young early-onset type 2 diabetes in a Chinese population

New clinical screening strategy to distinguish HNF1A variant-induced diabetes from young early-onset type 2 diabetes in a Chinese population

ObjectiveMaturity-onset diabetes of the young caused by hepatocyte nuclear factor-1 alpha (HNF1A) variants (HNF1A-MODY) is a common form of monogenetic diabetes. Although patients with HNF1A-MODY might specifically benefit from sulfonylurea treatment, available methods for screening this specific ty...

Full description

Bibliographic Details
Main Authors: Yumin Ma, Siqian Gong, Xirui Wang, Xiaoling Cai, Xinhua Xiao, Weijun Gu, Jinkui Yang, Liyong Zhong, Jianzhong Xiao, Simin Zhang, Xianghai Zhou, Lingli Zhou, Yingying Luo, Qian Ren, Xiuting Huang, Xueying Gao, Qiuping Wang, Mengdie Hu, Xueyao Han
Format: Article
Language:English
Published: BMJ Publishing Group 2020-04-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/8/1/e000745.full

Internet

https://drc.bmj.com/content/8/1/e000745.full

Similar Items